Skip to main content

Table 2 Frequency of adverse events

From: Tolerability and safety of urotainer® polihexanide 0.02% in catheterized patients: a prospective cohort study

  N = 32
Not related Related
Mild Moderate Severe Mild Moderate Severe
n (%) n (%) n (%) n (%) n (%) n (%)
Abdominal pain 1 (3.1) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Diarrhoea 1 (3.1) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Pain 0 (0.0) 0 (0.0) 0 (0.0) 1 (3.1) 0 (0.0) 0 (0.0)
Pyrexia 0 (0.0) 1 (3.1) 0 (0.0) 1 (3.1) 0 (0.0) 0 (0.0)
Urinary tract infection 0 (0.0) 0 (0.0) 0 (0.0) 1 (3.1) 0 (0.0) 0 (0.0)
Fall 1 (3.1) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Muscle spasms 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 2 (6.3) 0 (0.0)
Bladder discomfort 0 (0.0) 0 (0.0) 0 (0.0) 1 (3.1) 0 (0.0) 0 (0.0)
Bladder irritation 0 (0.0) 0 (0.0) 0 (0.0) 1 (3.1) 0 (0.0) 0 (0.0)
Bladder pain 0 (0.0) 0 (0.0) 0 (0.0) 2 (6.3) 2 (6.3) 0 (0.0)
Bladder spasm 0 (0.0) 0 (0.0) 0 (0.0) 6 (18.8) 3 (9.4) 0 (0.0)
Urethral pain 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 1 (3.1) 0 (0.0)
Urinary incontinence 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 1 (3.1) 0 (0.0)
Cough 0 (0.0) 1 (3.1) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Hypertension 1 (3.1) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)